WallStreetZenWallStreetZen

NASDAQ: IOVA
Iovance Biotherapeutics Inc Stock Ownership - Who owns Iovance Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Iovance Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel Gordon KirbyChief Commercial Officer2025-06-0530,000$1.84
$55.20kBuy
Jeanmarc BelleminChief Financial Officer2025-06-024,464$1.76
$7.86kSell
Frederick G. VogtInterim CEO General Counsel2025-06-0222,127$1.76
$38.94kSell
Igor BilinskyChief Operating Officer2025-06-026,250$1.76
$11.00kSell
Finckenstein Friedrich GrafChief Medical Officer2025-06-026,448$1.76
$11.35kSell
Raj K. PuriChief Regulatory Officer2025-06-022,467$1.76
$4.34kSell
Raj K. PuriChief Regulatory Officer2025-05-235,600$1.74
$9.74kBuy
Frederick G. VogtInterim CEO General Counsel2025-05-1425,000$1.69
$42.25kBuy
Raj K. PuriChief Regulatory Officer2025-03-142,509$3.59
$9.01kSell
Jeanmarc BelleminChief Financial Officer2025-03-0331,734$4.04
$128.21kSell

1 of 4

IOVA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IOVA insiders and whales buy or sell their stock.

IOVA Shareholders

What type of owners hold Iovance Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ayer Capital Management LP155.65%563,224,483$1.26BInsider
Paul L. Kessler114.84%415,566,430$926.71MInsider
Mhr Fund Management LLC8.01%28,967,103$64.60MInstitution
Wayne P. Rothbaum7.76%28,067,333$62.59MInsider
Vanguard Group Inc6.93%25,076,472$55.92MInstitution
Blackrock Inc6.42%23,236,812$51.82MInstitution
Atlantic Hamilton5.79%20,960,016$46.74MInsider
David J. Voyticky5.25%18,981,082$42.33MInsider
Sanford Hillsberg3.73%13,500,000$30.11MInsider
Long Focus Capital Management LLC3.27%11,820,000$26.36MInstitution

1 of 3

IOVA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IOVA16.88%83.12%Net SellingNet Selling
TSHA89.39%10.61%Net BuyingNet Selling
EYPT25.81%74.19%Net SellingNet Selling
NAGE17.10%82.90%Net Buying
AKBA41.23%7.72%Net SellingNet Selling
View Top Biotech Stocks

Iovance Biotherapeutics Stock Ownership FAQ

Who owns Iovance Biotherapeutics?

Iovance Biotherapeutics (NASDAQ: IOVA) is owned by 60.83% institutional shareholders, 299.58% Iovance Biotherapeutics insiders, and 0.00% retail investors. Ayer Capital Management LP is the largest individual Iovance Biotherapeutics shareholder, owning 563.22M shares representing 155.65% of the company. Ayer Capital Management LP's Iovance Biotherapeutics shares are currently valued at $1.26B.

If you're new to stock investing, here's how to buy Iovance Biotherapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.